… up, the company expects the merger to be delayed: it … , though other drugs, such as flagship myeloma blockbuster Revlimid and … pipeline assets such as bb2121 are more vital … value creation opportunity of the acquisition of Celgene. Together with …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
